Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million

3 years ago

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 30, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS), a…

Verisante Technology Inc. Announces Non-Brokered Private Placement

3 years ago

VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Verisante Technology, Inc. (NEX:VER.H) (the "Company") is pleased to announce it…

Highmark Interactive Inc. Grant of Stock Options

3 years ago

TORONTO, ON / ACCESSWIRE / June 30, 2022 / Highmark Interactive Inc. (TSXV:HMRK) a global leader in digital health technologies…

Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement

3 years ago

VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to…

Canine Biologics Launches Adaptive Liquid Nutrition System for Critically Ill or Injured Dogs & Cats

3 years ago

NutriDapt liquid feeding system provides fast, easy, patient-specific nutrition for veterinary patients who need it mostDENVER, CO / ACCESSWIRE /…

GoodCap Pharmaceuticals Announces Publication of International Patent Application

3 years ago

Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap"), a biopharmaceutical company developing low-dose psychedelic therapies, is…

Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

3 years ago

CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…

Melzi Surgical to Participate at the Society of Robotic Surgery 2022 Annual Meeting

3 years ago

Company to showcase the Melzi Sharps Finder, a U.S. FDA registered device designed to locate lost needles and objects for…

9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome

3 years ago

Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE…

Enlighta Announces Appointment of John F. Wallace and Dr. Christina Gong as Independent Directors

3 years ago

TORTOLA, BVI / ACCESSWIRE / June 30, 2022 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") is pleased to announce…